Literature DB >> 32748150

ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers.

Edward Christopher Dee1, Morgan E Freret2, Jennifer Y Wo3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32748150     DOI： 10.1245/s10434-020-08970-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  7 in total

Review 1.  Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

Authors:  Anne M Horgan; Eitan Amir; Thomas Walter; Jennifer J Knox
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

2.  Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer.

Authors:  T Ebata; S Hirano; M Konishi; K Uesaka; Y Tsuchiya; M Ohtsuka; Y Kaneoka; M Yamamoto; Y Ambo; Y Shimizu; F Ozawa; A Fukutomi; M Ando; Y Nimura; M Nagino
Journal:  Br J Surg       Date:  2018-02       Impact factor: 6.939

Review 3.  New Horizons for Precision Medicine in Biliary Tract Cancers.

Authors:  Juan W Valle; Angela Lamarca; Lipika Goyal; Jorge Barriuso; Andrew X Zhu
Journal:  Cancer Discov       Date:  2017-08-17       Impact factor: 39.397

4.  Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.

Authors:  Julien Edeline; Meher Benabdelghani; Aurélie Bertaut; Jérôme Watelet; Pascal Hammel; Jean-Paul Joly; Karim Boudjema; Laetitia Fartoux; Karine Bouhier-Leporrier; Jean-Louis Jouve; Roger Faroux; Véronique Guerin-Meyer; Jean-Emmanuel Kurtz; Eric Assénat; Jean-François Seitz; Isabelle Baumgaertner; David Tougeron; Christelle de la Fouchardière; Catherine Lombard-Bohas; Eveline Boucher; Trevor Stanbury; Christophe Louvet; David Malka; Jean-Marc Phelip
Journal:  J Clin Oncol       Date:  2019-02-01       Impact factor: 44.544

5.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

6.  SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

Authors:  Edgar Ben-Josef; Katherine A Guthrie; Anthony B El-Khoueiry; Christopher L Corless; Mark M Zalupski; Andrew M Lowy; Charles R Thomas; Steven R Alberts; Laura A Dawson; Kenneth C Micetich; Melanie B Thomas; Abby B Siegel; Charles D Blanke
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 50.717

7.  Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.

Authors:  Rachna T Shroff; Erin B Kennedy; Melinda Bachini; Tanios Bekaii-Saab; Christopher Crane; Julien Edeline; Anthony El-Khoueiry; Mary Feng; Matthew H G Katz; John Primrose; Heloisa P Soares; Juan Valle; Shishir K Maithel
Journal:  J Clin Oncol       Date:  2019-03-11       Impact factor: 50.717
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.